The pharmaceutical industry is bracing for potentially major disruptions following US President Donald Trump’s announcement ...

Novo Nordisk's CEO is not worried about blockbuster semaglutide drugs being added to Medicare drug pricing negotiations this ...

President Donald Trump is facing pressure from U.S. hospitals and generic drugmakers to exempt medical goods from his new ...

US economists are looking for monthly headline CPI at 0.31%, which would keep the year-on-year rate at 2.9%. Core CPI is ...

In the early hours of September 14, 2021, three men parked in a quiet car park in the southern English market town of ...

The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower ...

Repatha: the frontline of US price battles Amgen's Repatha became the first in the new class of cholesterol-lowering PCSK9 inhibitor drugs to gain approval this year, getting the nod in Europe in ...

Drug price discounting is becoming more frequent and complex as industry and health care systems struggle to balance access and affordability. Leela Barham considers the pros and cons of keeping ...

Robin Fields ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. Vincent Gaynor remembers, almost to the minute, ...

President Trump’s tariffs in China are in place and hitting all products imported from the country — including a number of pharmaceutical drugs that Americans rely upon. Chinese imports ...

Shares of BridgeBio Pharma (NASDAQ:BBIO), currently valued at $5.88 billion, witnessed an uptick as Scotiabank (TSX:BNS) analyst Greg Harrison increased the price target to $49 from $48 while ...

US imports surged to a record high in December, official figures showed today as Donald Trump’s threat of tariffs triggered a ...